NKp80/CLEC5C, His, Human
NKp80/CLEC5C, His, Human

The purity of NKp80/CLEC5C, His, Human is greater than 95% as determined by SEC-HPLC.

NKp80/CLEC5C, His, Human

NKp80/CLEC5C, His, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

NKp80/CLEC5C, His, Human

NKp80, an activating homodimeric C-type lectin-like receptor (CTLR), is expressed on essentially all human natural killer (NK) cells and stimulates their cytotoxicity and cytokine release.
Z05696
¥72,752.00

Ask us a question
Product Introduction
Species Human
Protein Construction
His NKp80/CLEC5C (Leu60-Tyr231)_x000D_
Accession # Q9NZS2-1
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE
> 95% as determined by HPLC
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 20.94 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 35-50 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.

Examples
  • NKp80/CLEC5C, His, Human
    • NKp80/CLEC5C, His, Human

    The purity of NKp80/CLEC5C, His, Human is greater than 95% as determined by SEC-HPLC.

  • NKp80/CLEC5C, His, Human
    • NKp80/CLEC5C, His, Human

    NKp80/CLEC5C, His, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background NKp80, an activating homodimeric C-type lectin-like receptor (CTLR), is expressed on essentially all human natural killer (NK) cells and stimulates their cytotoxicity and cytokine release.
Synonyms Lectin-like receptor F1; KLRF1; CLEC5C; ML; NKp80

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.